Literature DB >> 14550894

An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans.

Sophie Goyard1, Hiroaki Segawa, Jennifer Gordon, Melissa Showalter, Robert Duncan, Salvatore J Turco, Stephen M Beverley.   

Abstract

Glycoconjugates have been shown to play important roles in Leishmania development. However, the ability to study these molecules and other processes would benefit greatly from improved methods for genetic manipulation and analysis of the amastigote stage. This is especially challenging for L. donovani, the agent of the most severe form of leishmaniasis, which can rapidly lose virulence during in vitro culture. Here we report on a clonal subline of an L. donovani 1S2D (LdBob or LdB), which differentiates readily from promastigotes to amastigotes in axenic culture, and maintains this ability during extended parasite cultivation in vitro. This derivative can be plated and transfected efficiently while grown as promastigotes or amastigotes. Importantly, LdB maintains the ability to differentiate while undergoing genetic alterations required for creation of gene knockouts and complemented lines. Like virulent L. donovani, LdB exhibits down-regulation of lipophosphoglycan (LPG) synthesis and up-regulation of A2 protein synthesis in amastigotes. We showed that knockouts of LPG2, encoding a Golgi GDP-mannose transporter, eliminated phosphoglycan synthesis in LdB axenic amastigotes. These and other data suggest that LdB axenic amastigotes will be generally useful as a differentiation model in studies of gene expression, virulence, glycoconjugate function and drug susceptibility in L. donovani.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550894     DOI: 10.1016/s0166-6851(03)00142-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  98 in total

1.  Adaptive responses to purine starvation in Leishmania donovani.

Authors:  Nicola S Carter; Phillip A Yates; Sarah K Gessford; Sean R Galagan; Scott M Landfear; Buddy Ullman
Journal:  Mol Microbiol       Date:  2010-10       Impact factor: 3.501

Review 2.  Purine salvage in Leishmania: complex or simple by design?

Authors:  Jan M Boitz; Buddy Ullman; Armando Jardim; Nicola S Carter
Journal:  Trends Parasitol       Date:  2012-06-20

3.  The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis.

Authors:  Susan Wyllie; Stephen Patterson; Laste Stojanovski; Frederick R C Simeons; Suzanne Norval; Robert Kime; Kevin D Read; Alan H Fairlamb
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

4.  Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.

Authors:  Goutam Mandal; Mansi Sharma; Martin Kruse; Claudia Sander-Juelch; Laura A Munro; Yong Wang; Jenny Veide Vilg; Markus J Tamás; Hiranmoy Bhattacharjee; Martin Wiese; Rita Mukhopadhyay
Journal:  Mol Microbiol       Date:  2012-07-26       Impact factor: 3.501

5.  Purine-responsive expression of the Leishmania donovani NT3 purine nucleobase transporter is mediated by a conserved RNA stem-loop.

Authors:  M Haley Licon; Phillip A Yates
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

6.  Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation.

Authors:  A Saxena; T Lahav; N Holland; G Aggarwal; A Anupama; Y Huang; H Volpin; P J Myler; D Zilberstein
Journal:  Mol Biochem Parasitol       Date:  2006-12-12       Impact factor: 1.759

7.  Genetic selection for a highly functional cysteine-less membrane protein using site saturation mutagenesis.

Authors:  Cassandra S Arendt; Keirei Ri; Phillip A Yates; Buddy Ullman
Journal:  Anal Biochem       Date:  2007-03-30       Impact factor: 3.365

8.  Role of prostaglandin F2α production in lipid bodies from Leishmania infantum chagasi: insights on virulence.

Authors:  Théo Araújo-Santos; Nilda E Rodríguez; Sara Moura-Pontes; Upasna Gaur Dixt; Daniel R Abánades; Patrícia T Bozza; Mary E Wilson; Valéria Matos Borges
Journal:  J Infect Dis       Date:  2014-05-21       Impact factor: 5.226

9.  Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.

Authors:  Julien Pedron; Clotilde Boudot; Sébastien Hutter; Sandra Bourgeade-Delmas; Jean-Luc Stigliani; Alix Sournia-Saquet; Alain Moreau; Elisa Boutet-Robinet; Lucie Paloque; Emmanuelle Mothes; Michèle Laget; Laure Vendier; Geneviève Pratviel; Susan Wyllie; Alan Fairlamb; Nadine Azas; Bertrand Courtioux; Alexis Valentin; Pierre Verhaeghe
Journal:  Eur J Med Chem       Date:  2018-06-05       Impact factor: 6.514

Review 10.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.